Navigation Links
Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting

ounding smooth muscle cells -and associated innervations - found in the blood vessels of healthy tissues. Thus, this technology could increase blood flow in tumors, allowing the delivery of cytotoxic agents more selectively to those tumors. Spectrum has proprietary worldwide rights to SPI-1620. SPI-1620 is expected to enter clinical trials later this year.

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease. For more information, please visit our website at www.spectrumpharm.com.

Forward-looking statement -- This press release may contain forward- looking statements regarding future events and the future performance of Spectrum Pharmaceuticals that involve risks and uncertainties that could cause actual results to differ materially. These statements include but are not limited to statements that relate to our business and its future, Spectrum's ability to identify, acquire, develop and commercialize its portfolio of drug candidates, the Company's promising pipeline, our team's ability to identify promising drugs and move these drugs through development and toward commercialization, the safety and efficacy of EOquin, satraplatin, and SPI- 1620, the initiation of and enrollment of patients in a Phase 3 trial of EOquin in non-inv
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:12/15/2009)... Dec. 15 Warner Chilcott plc (Nasdaq: ... Warner Chilcott Corporation (the "Company") has commenced a ... to the conditions set forth in the Company,s ... December 15, 2009 (the "Offer to Purchase"), for ... subordinated notes due 2015 (the "Notes"). ,, The ...
(Date:12/15/2009)... DIEGO, Dec. 15 Volcano Corporation (Nasdaq: ... intravascular therapy guidance tools - including Fractional Flow ... and Optical Coherence Tomography (OCT) - designed to ... peripheral vascular disease, announced today the placement of ... s5 family of consoles was first launched in ...
(Date:12/15/2009)... 15 Fenwal Inc., a global leader focused ... care, reiterated its commitment to provide blood centers with ... despite a new lawsuit filed yesterday against Fenwal by ... introduced in 2003, is an advanced medical instrument used ... a single donor in about 30 minutes. ...
Breaking Medicine Technology:Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6Volcano Announces Installed Base Growth Milestone 2Volcano Announces Installed Base Growth Milestone 3Volcano Announces Installed Base Growth Milestone 4Volcano Announces Installed Base Growth Milestone 5Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 2Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 3Grapes and Grape Products Show Exciting Potential in Optimizing Health 56833 1Grapes and Grape Products Show Exciting Potential in Optimizing Health 56833 2Grapes and Grape Products Show Exciting Potential in Optimizing Health 56833 3American Brain Tumor Association Calls for Discovery Research 4965 1American Brain Tumor Association Calls for Discovery Research 4965 2Insite Security Hosts Webinar on Swine Flu Preparedness 56832 1Insite Security Hosts Webinar on Swine Flu Preparedness 56832 2
... and NYSE: SNY ) announced today that the ... in favor of the approval of Multaq(R) by the U.S. ... atrial fibrillation (AF). As demonstrated in the ATHENA trial, ... a clinical study a significant reduction in morbidity and mortality ...
... Alternext: ULU) announced that clinical evidence on ... the use of its patented Nanoflex(TM) Technology for Therapeutic ... Meeting in Los Angeles, California March 19-21. The ... on display during the meeting.Clinical evidence will be presented ...
Other Medicine Technology:FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone) 2FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone) 3ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009 2ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009 3
(Date:12/16/2009)... While many of the,pharma companies ... models,for new and inmarket drugs, MarketsandMarkets on ... to various players. These pharma,forecasting solutions are ... well as phase,III. These have a substantial ... market entry strategy, manufacturing planning, sales force,promotion, ...
(Date:12/16/2009)... County area dry cleaner Dryclean USA donates time and money to ... ... (PRWEB) Dec. 16, 2009 -- South Florida dry cleaner Dryclean ... with the charity Prints of Hope to help clothe ... needy families. Dryclean USA Florida will begin distributing cards, with ...
(Date:12/16/2009)... and Insoles Awarded American Podiatric Medical Association’s Seal of Acceptance ... ... 15, 2009 -- As shoppers continue their search for the ... and shop for items that are considered healthy for the ... footwear products, many of today’s most stylish items are also ...
(Date:12/16/2009)... Ennis & Ennis, P.A. will continue to offer free nationwide ... from serious Paxil side effects such as: Birth Defects, Attempted ... effects can call toll free at 1-800-856-6405 or go to ... an online case evaluation form. , ... ...
(Date:12/15/2009)... of the U.S. Senate to allow importation of ... more effective direct bulk purchasing of prescription drugs, ... industry controls the health reform debate, according Consumer ... Dorgan (D-ND) was a relatively modest proposal, far ... to directly negotiate discounts with drug manufacturers," said ...
Breaking Medicine News(10 mins):Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3Health News:Pay a Dollar, Dress a Child: Helping Struggling Families with Small Donations 2Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 2Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 3Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 4Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3
... research shows it does not damage cerebral blood vessels in ... studies looking at the same group of women found that ... not seem to be associated with early signs of cerebrovascular ... volume, not its effect on the brain lesions that indicate ...
... Abaxis, Inc. (Nasdaq: ABAX ), a ... today that Clint Severson, chairman and chief executive officer, ... Palm Beach Emerging Growth Institutional Investor Forum on Thursday, ... will be held at The Ritz-Carlton, Palm Beach, Florida. ...
... New research conducted at Columbia University Mailman School ... alcohol in predominantly African-American neighborhoods of New York ... residents. Prior studies have shown that alcohol advertisements ... the impact of such advertising on alcohol consumption ...
... Partnership Will Fund Breakthrough Research to Support the ... Jan. 12 When her doctor told her ... it early had greatly enhanced her odds of ... forms of cancer. But then she learned she ...
... particle syringe composed of polymer layers and nanoparticles may ... the rest of the body, according to a team ... and flexible enough to deliver a variety of substances., ... than they fear the disease they treat," says Huda ...
... are developing a set of standardized tests that could ... , The condition, which occurs once in every approximately ... presence of an extra 21st chromosome. Those with Down ... other health issues that include heart defects and the ...
Other Medicine News:Health News:HRT Shrinks the Brain 2Health News:HRT Shrinks the Brain 3Health News:Outdoor alcohol advertising and problem drinking among African-American women in NYC 2Health News:Susan G. Komen for the Cure(R) and Triple Negative Breast Cancer Foundation Unite to Fight Aggressive Form of Breast Cancer 2Health News:Susan G. Komen for the Cure(R) and Triple Negative Breast Cancer Foundation Unite to Fight Aggressive Form of Breast Cancer 3Health News:Tiny capsules deliver 2Health News:Standardized test battery to aid those with Down syndrome 2Health News:Standardized test battery to aid those with Down syndrome 3Health News:Standardized test battery to aid those with Down syndrome 4Health News:Standardized test battery to aid those with Down syndrome 5Health News:Standardized test battery to aid those with Down syndrome 6
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... Delivering optimum performance with maximum comfort, ... for medical professionals worldwide. All SheerVision ...
... Experience the finest surgical-quality loupes available ... the standard for innovative optical design, ... support. Delivering optimum performance with maximum ... choice for medical professionals worldwide. All ...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... optimum performance with maximum comfort, SheerVision ... medical professionals worldwide. All SheerVision loupes ...
Medicine Products: